BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sakurai S, Kato H, Yoshida Y, Sugawara Y, Fujisawa M, Yasumoto A, Matsumoto M, Fujimura Y, Yatomi Y, Nangaku M. Profiles of Coagulation and Fibrinolysis Activation-Associated Molecular Markers of Atypical Hemolytic Uremic Syndrome in the Acute Phase. J Atheroscler Thromb 2020;27:353-62. [PMID: 31484852 DOI: 10.5551/jat.49494] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Turudic D, Milosevic D, Bilic K, Prohászka Z, Bilic E. A Limited Course of Eculizumab in a Child with the Atypical Hemolytic Uremic Syndrome and Pre-B Acute Lymphoblastic Leukemia on Maintenance Therapy: Case Report and Literature Review. JCM 2022;11:2779. [DOI: 10.3390/jcm11102779] [Reference Citation Analysis]
2 Shimizu J, Fujino K, Sawai T, Tsujita Y, Tabata T, Eguchi Y. Association between plasma complement factor H concentration and clinical outcomes in patients with sepsis. Acute Med Surg 2021;8:e625. [PMID: 33510899 DOI: 10.1002/ams2.625] [Reference Citation Analysis]
3 Al-Tamimi M, Qiao J, Gardiner EE. The utility of platelet activation biomarkers in thrombotic microangiopathies. Platelets 2022;:1-9. [PMID: 35287530 DOI: 10.1080/09537104.2022.2026912] [Reference Citation Analysis]
4 Bray MA, Sartain SE, Gollamudi J, Rumbaut RE. Microvascular thrombosis: experimental and clinical implications. Transl Res 2020;225:105-30. [PMID: 32454092 DOI: 10.1016/j.trsl.2020.05.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
5 Takahashi M, Deguchi A, Nishihara H, Asou M, Asakawa T, Araki M. Quetiapine-induced thrombotic microangiopathy in a patient on maintenance dialysis. CEN Case Rep 2021;10:159-64. [PMID: 32981026 DOI: 10.1007/s13730-020-00536-z] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]